Literature DB >> 4030393

Placental alkaline phosphatase in benign and malignant endometrium.

J O Davies, K Howe, G M Stirrat, C A Sunderland.   

Abstract

The presence of placental alkaline phosphatase has been demonstrated immunohistochemically using a monoclonal antibody, in frozen sections of human endometrium. The enzyme is present in glandular epithelium, but is found most commonly in the surface epithelial layer throughout the menstrual cycle. It has also been demonstrated in malignant endometrial epithelium in eight out of twelve patients.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4030393     DOI： 10.1007/bf01003200

Source DB:  PubMed          Journal:  Histochem J        ISSN： 0018-2214


  10 in total

1.  A histochemical study of the distribution of alkaline phosphatase in various normal and neoplastic tissues.

Authors:  E A Kabat; J Furth
Journal:  Am J Pathol       Date:  1941-05       Impact factor: 4.307

2.  Increased incidence of placenta-like alkaline phosphatase activity in breast and genitourinary cancer.

Authors:  B J Cadeau; M E Blackstein; A Malkin
Journal:  Cancer Res       Date:  1974-04       Impact factor: 12.701

3.  New observations on the Regan isoenzyme of alkaline phosphatase in cancer patients.

Authors:  L Nathanson; W H Fishman
Journal:  Cancer       Date:  1971-06       Impact factor: 6.860

4.  Placenta-like alkaline phosphatase in gynecological cancers.

Authors:  J A Kellen; R S Bush; A Malkin
Journal:  Cancer Res       Date:  1976-01       Impact factor: 12.701

5.  Immunohistology of normal and ovarian cancer tissue with a monoclonal antibody to placental alkaline phosphatase.

Authors:  C A Sunderland; J O Davies; G M Stirrat
Journal:  Cancer Res       Date:  1984-10       Impact factor: 12.701

6.  Placental-type alkaline phosphatase in ovarian cancer fluids and tissues.

Authors:  G J Doellgast; H D Homesley
Journal:  Obstet Gynecol       Date:  1984-03       Impact factor: 7.661

Review 7.  Biochemical markers in the plasma and tumors of patients with gynecologic malignancies.

Authors:  J R van Nagell; E S Donaldson; M B Hanson; E C Gay; E J Pavlik
Journal:  Cancer       Date:  1981-07-15       Impact factor: 6.860

8.  Heat-stable alkaline phosphatase in uterine cancer, with special reference to its histochemical heat-stability and the L-phenylalanine inhibition test.

Authors:  S Nozawa; H Ohta; S Izumi; S Hayashi; F Tsutsui; S Kurihara; K Watanabe
Journal:  Histochem J       Date:  1981-11

9.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.

Authors:  C J Barnstable; W F Bodmer; G Brown; G Galfre; C Milstein; A F Williams; A Ziegler
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

10.  Placental alkaline phosphatase in nonmalignant human cervix.

Authors:  D J Goldstein; L Blasco; H Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205
  10 in total
  2 in total

1.  Ecto-nucleotidases distribution in human cyclic and postmenopausic endometrium.

Authors:  Elisabet Aliagas; August Vidal; Benjamín Torrejón-Escribano; Maria del Rosario Taco; Jordi Ponce; Inmaculada Gómez de Aranda; Jean Sévigny; Enric Condom; Mireia Martín-Satué
Journal:  Purinergic Signal       Date:  2012-12-06       Impact factor: 3.765

2.  Placental-type alkaline phosphatase in cervical neoplasia.

Authors:  P J McLaughlin; P H Warne; G E Hutchinson; P M Johnson; D F Tucker
Journal:  Br J Cancer       Date:  1987-02       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.